PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma.
Saved in:
| Title: | PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. |
|---|---|
| Authors: | Zhao, Yaning1,2 (AUTHOR), Li, Luxi3 (AUTHOR), Jiang, Yu3 (AUTHOR), Sun, Yujiao1,2 (AUTHOR), Xu, Yi4 (AUTHOR), Ye, Xinyi3 (AUTHOR), Zhang, Fangming5 (AUTHOR), Zhu, Fenxia1,2 (AUTHOR), Pan, Yunzhi3 (AUTHOR) yunzhipan@126.com, Ma, Sai4 (AUTHOR) marseillems@outlook.com |
| Source: | Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189681537 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhao%2C+Yaning%22">Zhao, Yaning</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Luxi%22">Li, Luxi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Yu%22">Jiang, Yu</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Yujiao%22">Sun, Yujiao</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Yi%22">Xu, Yi</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ye%2C+Xinyi%22">Ye, Xinyi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Fangming%22">Zhang, Fangming</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Fenxia%22">Zhu, Fenxia</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Yunzhi%22">Pan, Yunzhi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> yunzhipan@126.com</i><br /><searchLink fieldCode="AR" term="%22Ma%2C+Sai%22">Ma, Sai</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> marseillems@outlook.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Scientific+Reports%22">Scientific Reports</searchLink>. 11/28/2025, Vol. 15 Issue 1, p1-15. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189681537 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-025-26858-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 1 Titles: – TitleFull: PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhao, Yaning – PersonEntity: Name: NameFull: Li, Luxi – PersonEntity: Name: NameFull: Jiang, Yu – PersonEntity: Name: NameFull: Sun, Yujiao – PersonEntity: Name: NameFull: Xu, Yi – PersonEntity: Name: NameFull: Ye, Xinyi – PersonEntity: Name: NameFull: Zhang, Fangming – PersonEntity: Name: NameFull: Zhu, Fenxia – PersonEntity: Name: NameFull: Pan, Yunzhi – PersonEntity: Name: NameFull: Ma, Sai IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 11 Text: 11/28/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20452322 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Scientific Reports Type: main |
| ResultId | 1 |